2023 Exhibitors Search
Xcell Therapeutics Inc.
| Exhibit Item |
Bio · Medical · Pharma
|
|---|---|
| Country | Korea, South |
| Tel (Rep.) | 02-863-1331 |
| Website | http://www.xcell.media |
Company Introduction
- Xcell Therapeutics Inc. is a leading company in the field of medium development that launched the world`s first GMP-grade next-generation chemically defined medium for human MSCs, and aims to grow into a global medium development company that meets the demands of the advanced regenerative medicine and cell-gene therapy (CGT) markets.
- We are expanding our pipeline of cell-specific media targeting various cells such as MSCs, exosomes, NK, and T by utilizing "cell-specific media development source technology" (XPorT : Xcell`s Platform ; optimized media recipe for Therapeutics).
- Successfully launched and commercialized the world`s first GMP-grade chemically defined medium for MSCs, CellCor CD MSC, followed the launch of CellCor SFD MSC, a serum-free medium for MSCs.
- We are expanding our pipeline of cell-specific media targeting various cells such as MSCs, exosomes, NK, and T by utilizing "cell-specific media development source technology" (XPorT : Xcell`s Platform ; optimized media recipe for Therapeutics).
- Successfully launched and commercialized the world`s first GMP-grade chemically defined medium for MSCs, CellCor CD MSC, followed the launch of CellCor SFD MSC, a serum-free medium for MSCs.
Promotional Video
Exhibit Description
Chemically Defined Solution for Ideal MSC Research
- High Performance: CellCor shows stable cell size, PDT, and ACN from young to old passages(P4-P15).
- High Stability & Low immunogenicity:CellCor MSC CD AOF does not contain any animal-derived materials,
resulting in very low levels of xenoantigen-triggered immune, inflammatory response.
- High Performance: CellCor shows stable cell size, PDT, and ACN from young to old passages(P4-P15).
- High Stability & Low immunogenicity:CellCor MSC CD AOF does not contain any animal-derived materials,
resulting in very low levels of xenoantigen-triggered immune, inflammatory response.
Co-Exhibitor or
Partner’s Information
| Company Name | Country | Website |
|---|
KYUNGYON EXHIBITION CORP.